P19-39. Vaccibodies: a novel vaccine strategy for HIV that target viral antigens to APC

por Øynebråten, I, Fredriksen, A, Barouch, D, Bogen, B
Publicado 2009

Design of lipid nanoparticle delivery agents for multivalent display of recombinant Env trimers in HIV vaccination

por Pejawar-Gaddy, S, Kovacs, J, Barouch, D, Chen, B, Irvine, D
Publicado 2012

Stability and neutralization capacity of a novel mosaic HIV-1 gp140 trimer in a guinea pig model

por Nkolola, JP, Kovacs, JM, Korber, B, Chen, B, Seaman, M, Barouch, D
Publicado 2012

Engineered microneedle arrays for transcutaneous HIV vaccine delivery

por DeMuth, P, Huang, B, Min, Y, Barouch, D, Hammond, P, Irvine, D
Publicado 2012

HIV-1 envelope trimer elicits higher neutralizing antibody responses than monomeric gp120

por Kovacs, JM, Nkolola, JP, Peng, H, Cheung, A, Perry, J, Miller, CA, Seaman, MS, Barouch, D, Chen, B
Publicado 2012

Vector induced skewing of antibody Fc-effector functions

por Chung, A, Dugast, A, Robinson, H, Chan, Y, Ackerman, ME, Cox, J, Koff, W, Barouch, D, Rerks-Ngarm, S, Michael, N, Kim, J, Alter, G
Publicado 2012

NS1 DNA vaccination protects against Zika infection through T cell–mediated immunity in immunocompetent mice

por Grubor-Bauk, B., Wijesundara, D. K., Masavuli, M., Abbink, P., Peterson, R. L., Prow, N. A., Larocca, R. A., Mekonnen, Z. A., Shrestha, A., Eyre, N. S., Beard, M. R., Gummow, J., Carr, J., Robertson, S. A., Hayball, J. D., Barouch, D. H., Gowans, E. J.
Publicado 2019